BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8249381)

  • 21. [Aztreonam. A small-spectrum antibiotic in gram-negative infections].
    Sander J
    Tidsskr Nor Laegeforen; 1991 Aug; 111(18):2277-8. PubMed ID: 1896987
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
    Malcangi A; Pesce S; Vitale M; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New trends in paediatric antibiotic therapy.
    Principi N
    Drugs Exp Clin Res; 1987; 13(9):589-93. PubMed ID: 3428136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aztreonam.
    Tunkel AR; Scheld WM
    Infect Control Hosp Epidemiol; 1990 Sep; 11(9):486-94. PubMed ID: 2230052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of aztreonam in urinary tract infections.
    Roberts JA
    Urology; 1988 Jun; 31(6 Suppl):39-44. PubMed ID: 3287749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aztreonam: a narrow spectrum against gram-negative aerobes.
    Drug Ther Bull; 1987 Nov; 25(22):86-8. PubMed ID: 3315541
    [No Abstract]   [Full Text] [Related]  

  • 27. Aztreonam: clinical pharmacology.
    Stutman HR
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S104-8; discussion S128-32. PubMed ID: 2682507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Brogden RN; Heel RC
    Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of 315neutropenic febrile episodes in a cancer center].
    Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J
    Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New antibiotic agents for bloodstream infections.
    Vergidis PI; Falagas ME
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S60-5. PubMed ID: 18723329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
    Rolston KV
    Clin Infect Dis; 2005 Apr; 40 Suppl 4():S246-52. PubMed ID: 15768330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of infections in the neutropenic child with cancer.
    Mitchell CD
    Pediatr Ann; 1988 Nov; 17(11):677-8, 680-6. PubMed ID: 3148899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
    Raymond DP; Pelletier SJ; Crabtree TD; Evans HL; Pruett TL; Sawyer RG
    Crit Care Med; 2003 Apr; 31(4):1035-41. PubMed ID: 12682469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aztreonam.
    Cunha BA
    Urology; 1993 Mar; 41(3):249-58. PubMed ID: 8442309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the pharmacokinetics and pharmacodynamics of aztreonam.
    Ramsey C; MacGowan AP
    J Antimicrob Chemother; 2016 Oct; 71(10):2704-12. PubMed ID: 27334663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
    Fayed DF; Dahmash NS; Saddique AA; Shibl AM
    J Chemother; 1992 Jun; 4(3):167-70. PubMed ID: 1517810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imipenem in acute lung infections and bacterial re-exacerbations of chronic obstructive lung disease.
    Pozzi E; De Rose V
    J Chemother; 1991 Jan; 3 Suppl 1():213-7. PubMed ID: 12041768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.